We discuss emerging data on the role and inter-relationship among macrophage migration inhibitory factor (MIF), prostaglandin E2 (PGE2), and estrogen receptors alpha (ER-α) and beta (ER-β), and the potential utility of targeting these factors in endometriosis treatment. The gene discussed is ESR1; the disease is endometriosis.